Optiray 300 636 mg/mL

Optiray 300 636 mg/mL is a radiopaque contrast agent used for imaging procedures. It enhances visibility during X-rays and CT scans, aiding in diagnostic accuracy. This injection is designed for intra-arterial and intravenous administration.

Optiray 300 636 mg/mL is primarily used as a contrast medium to improve the visibility of internal structures during imaging procedures. It is commonly employed in X-rays and CT scans to help healthcare professionals identify and diagnose various conditions. The primary use of Optiray 300 is to enhance the clarity of images, making it easier to detect abnormalities or areas of concern.

When administered, Optiray 300 636 mg/mL may cause a temporary warming sensation or a metallic taste in the mouth. Some individuals might experience mild discomfort at the injection site. These effects are generally short-lived and subside quickly.

Optiray 300 636 mg/mL should be used with caution in individuals with a history of allergic reactions to contrast agents. It is important to inform healthcare professionals about any existing medical conditions or allergies before administration. Proper handling and storage are essential to maintain the integrity of the product.

Optiray 300 636 mg/mL may interact with certain medications or substances. It is advisable to consult with a healthcare professional regarding potential interactions, especially with other contrast agents or medications that affect kidney function. Alcohol and other substances that affect kidney function should be avoided.